Fund Holdings — Samsara BioCapital, LLC

Total Portfolio Value:
$728.58M
Total Bought:
$134.75M
Total Sold:
$210.50M
Net Transaction:
-$75.75M
Notable People:
Michael Philip Dybbs
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Scholar Rock Holding Corporation(SRRK)6,788,6095,612,896-1,175,713$54.38M$242.59M33.30%+$188.21M
Cargo Therapeutics Inc4,415,6894,415,6890$81.47M$63.67M8.74%-$17.80M
Septerna, Inc.(SEPN)02,768,520+2,768,520$0$63.40M8.70%+$63.40M
Mineralys Therapeutics, Inc.(MLYS)5,074,9165,074,9160$61.46M$62.47M8.57%+$1.01M
Neurogene Inc.(NGNE)1,267,7901,717,127+449,337$53.20M$39.25M5.39%-$13.94M
Upstream Bio, Inc.(UPB)02,217,146+2,217,146$0$36.45M5.00%+$36.45M
LENZ Therapeutics, Inc.(LENZ)1,208,473986,981-221,492$28.69M$28.49M3.91%-$195.0K
Alumis Inc3,266,4983,266,4980$34.89M$25.67M3.52%-$9.21M
Arcellx Inc
COMMON STOCK
353,641253,641-100,000$29.53M$19.45M2.67%-$10.08M
Zymeworks Inc.(ZYME)1,000,0001,000,0000$12.55M$14.64M2.01%+$2.09M
Jasper Therapeutics, Inc.(JSPR)584,642584,6420$11.00M$12.50M1.72%+$1.50M
Avadel Pharmaceuticals Plc967,527967,5270$12.69M$10.17M1.40%-$2.52M
Rhythm Pharmaceuticals, Inc.(RYTM)172,647172,6470$9.04M$9.66M1.33%+$619.8K
Nkarta, Inc.(NKTX)3,768,0353,768,0350$17.03M$9.38M1.29%-$7.65M
Contineum Therapeutics, Inc.CL A(CTNM)588,816588,8160$11.27M$8.63M1.18%-$2.64M
Palvella Therapeutics, Inc.(PVLA)0679,486+679,486$0$8.15M1.12%+$8.15M
Acelyrin Inc2,523,0222,523,0220$12.44M$7.92M1.09%-$4.52M
OnKure Therapeutics, Inc.CL A(OKUR)0824,155+824,155$0$7.09M0.97%+$7.09M
Cypherpunk Technologies Inc.(CYPH)2,442,3522,442,3520$6.28M$7.02M0.96%+$744.9K
ABIVAX Société AnonymeADS(ABVX)850,000850,0000$9.79M$6.22M0.85%-$3.57M
Aclaris Therapeutics, Inc.(ACRS)696,1712,385,060+1,688,889$800.6K$5.91M0.81%+$5.11M
Gossamer Bio, Inc.(GOSS)6,130,2686,130,2680$6.05M$5.55M0.76%-$501.5K
Climb Bio, Inc.(CLYM)2,609,1142,609,1140$13.28M$4.70M0.64%-$8.58M
Verona Pharma PlcADS195,22597,625-97,600$5.62M$4.53M0.62%-$1.08M
Inozyme Pharma Inc1,562,5001,562,5000$8.17M$4.33M0.59%-$3.84M
Sutro Biopharma, Inc.(STRO)2,196,8142,196,8140$7.60M$4.04M0.55%-$3.56M
Artiva Biotherapeutics, Inc.(ARTV)291,666291,6660$4.51M$2.94M0.40%-$1.57M
vTv Therapeutics Inc.CL A(VTVT)206,784206,7840$2.81M$2.86M0.39%+$50.4K
Tango Therapeutics, Inc.(TNGX)630,000630,0000$4.85M$1.95M0.27%-$2.90M
Day One Biopharmaceuticals I
COM
147,319147,3190$2.05M$1.87M0.26%-$185.6K
Immatics N.V.SHS(IMTX)198,000198,0000$2.26M$1.41M0.19%-$851.4K
Prime Medicine, Inc.(PRME)540,304405,228-135,076$2.09M$1.18M0.16%-$907.7K
Terns Pharmaceuticals Inc202,348202,3480$1.69M$1.12M0.15%-$566.6K
Hillevax Inc799,274399,637-399,637$1.41M$827.2K0.11%-$579.5K
Curis, Inc.(CRIS)0198,216+198,216$0$606.5K0.08%+$606.5K
Janux Therapeutics, Inc.(JANX)22,52611,263-11,263$1.02M$603.0K0.08%-$420.3K
Bolt Biotherapeutics Inc1,049,1531,049,1530$679.9K$561.4K0.08%-$118.4K
Lyra Therapeutics Inc2,780,2611,965,689-814,572$714.5K$405.7K0.06%-$308.8K
Allakos Inc172,089172,0890$112.4K$208.2K0.03%+$95.8K
Kronos Bio Inc78,13178,1310$78.1K$74.2K0.01%-$3.9K
Allovir Inc82,33682,3360$66.6K$34.6K0.00%-$32.0K
Nuvation Bio Inc.W EXP 02 10 202(NUVB)133,333133,3330$13.1K$30.7K0.00%+$17.6K
Surrozen, Inc.W EXP 08 01 203(SRZN)99,99999,9990$1.0K$2.1K0.00%+$1.1K
Bicara Therapeutics Inc35,0000-35,000$891.5K$0—-$891.5K
Io Biotech Inc3,640,0150-3,640,015$3.82M$0—-$3.82M
Syros Pharmaceuticals Inc1,786,4270-1,786,427$3.84M$0—-$3.84M
Viracta Therapeutics Inc689,7090-689,709$159.6K$0—-$159.6K
Page 1 of 1
Samsara BioCapital, LLC — 13F Holdings — Q4 2024 | TickerTrail